Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC

Recruiting now · Phase 2

Conditions studied: Breast Cancer Recurrent

In brief

This is a prospective phase 2 study to use Functional Precision Oncology (FPO) to predict, prevent and treat early metastatic recurrence in subjects with HR-low/Her2 negative or triple negative breast cancer.

Key facts

Study ID

NCT05464082

Run by

University of Utah

People needed

80

Starts

2023-01-06

Expected to finish

2028-09-30

Last updated by the study team

2026-02-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.